Department of Circulation and Medical Imaging
Trondheim, 7491, Norway
NCT Number: NCT05691166
This study will investigate the effects of 12 months of high-intensity progressive resistance training compared with a control group on fall-rate in older adults with sarcopenia.
This study is active but is not currently recruiting participants.
80 year and older
All sexes
Interventional
Not applicable
Trondheim, 7491, Norway
Despite the wealth of theoretical benefits, existing literature on resistance training for falls prevention is not conclusive, given the sub-optimal resistance training paradigms, poor study quality, and use of multimodal training interventions, precluding isolation of the resistance training benefits. It is also possible that resistance training benefits for falls reduction will be most evident in those with sarcopenia to begin with as a risk factor for their falls. We will therefore conduct a randomised, controlled trial assessing the effects of resistance training reduce falls in the oldest old adults with sarcopenia, as well as to increase strength and muscle mass.
Amendment 2023-12-15: The description of the control condition was updated following ethics committee approval. Referral to the general practitioner for follow-up was replaced with provision of written information on current physical activity recommendations for older adults. This change was made to improve acceptability and feasibility of the control condition; the study outcomes and intervention were unchanged.
Amendments: 2024-09-18. We updated the low grip-strength inclusion criterion from [Men:<39.6kg, Women:<21.4kg] to [Men:<41.6kg, Women:23.4kg] based on normative values (Ref: Svinøy, O. E., Hilde, G., Bergland, A., & Strand, B. H. [2023]).
Extension amendment (2025-09-02): With new funding and ethics approval (REK 2022/462261), we added post-trial follow-up at 24 and 36 months to evaluate disability-free survival and the durability of effects on falls and several secondary outcomes. Falls during follow-up are collected via 12-month recall. No changes to interventions or the prespecified 0-12-month primary endpoints.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supervised high-intensity progressive resistance training twice per week for 12 months
Referred to general practitioner (GP) for further follow-up. The GPs will be informed about participants sarcopenia status with results from assessments of muscle strength, muscle mass, and physical performance. The management of the sarcopenia is at the GPs own discretion.
Time frame: 12 months
Relative risk for falls, fall rate per person years. Self-report.
Time frame: 6 months
Relative risk for falls, fall rate per person years. Self-report.
Time frame: 6, 12, 24, and 36 months.
Number of falls, number of fallers/nonfallers/frequent fallers, and time to first fall. Self-report.
Time frame: 6, 12, 24, 36 months
Number of falls requiring medical attention. Collected via self-report and ascertained by linkage to the Norwegian Patient Registry and medical journals with the use of unique 11-digit Norwegian national identification number for each participant.
Time frame: 6, 12, 24, 36 months
Classified according to the International Classification of Diseases, 11th revision, classification system. Peripheral fracture rate per person-years, number of peripheral fractures, number of people sustaining peripheral fractures, and number of people sustaining multiple events. Collected via self-report and ascertained by linkage to the Norwegian Patient Registry and medical journals with the use of unique 11-digit Norwegian national identification number for each participant.
Time frame: 6 and 12 months
1-repetition maximum leg press and leg extension
Time frame: 6, 12, 24, 36 months
Maximal isometric handgrip strength
Time frame: 6 and 12 months
Muscular power assessed using a force platform installed on a leg press machine
Time frame: 6, 12, 24, 36 months
Physical performance using the Short Physical Performance Battery
Time frame: 6, 12, 24, 36 months
Static and dynamic balance using the Mini-Balance Evaluation Systems Test (BESTest)
Time frame: 6, 12, 24, 36 months
Stretch stature using a wall-mounted stadiometer
Time frame: 6, 12, 24, 36 months
Body mass estimated using multi-frequency bioelectrical impedance analysis
Time frame: 6, 12, 24, 36 months
Estimated using multi-frequency bioelectrical impedance analysis. Fat mass, skeletal muscle mss, appendicular skeletal muscle mass.
Time frame: 6 and 12 months
Waist, arm, and calf circumference
Time frame: 6, 12, 24, 36 months
Systolic and diastolic blood pressure, and resting heart rate measured after 5 minutes of seated resting using an automated blood pressure device
Time frame: 6, 12, 24, 36 months
Systolic and diastolic blood pressure response 1, and 3-min after standing up
Time frame: 6, 12, 24, 36 months
Self-reported physical activity levels
Time frame: 6, 12, 24, 36 months
Health-related quality of life assessed using the 12-item Short-form health survey
Time frame: 6, 12, 24, 36 months
Fear of falling assessed using the Falls Efficacy Scale-International
Time frame: 6 and 12 months
Cognitive function evaluated using The Mini Mental State Examination
Time frame: 6, 12, 24, 36 months
Levels of depression measured via the Geriatric Depression Scale.
Time frame: 6, 12, 24, 36 months
Physical frailty assessed according to Fried's frailty phenotype
Time frame: 6, 12, 24, 36 months
Nutritional status assessed using the Mini-nutritional Assessment Short form.
Time frame: 6, 12, 24, 36 months
Sleep quality assessed using the Pittsburgh Sleep Quality Index
Time frame: 0-12 months and 0-36 months
Information about hospitalisations due to falls and fall-related injuries will be collected by means of electronic linkage to the Norwegian Patient Registry and medical journals with the use of a unique 11-digit Norwegian national identification number for each participant.
Time frame: 0-12 months and 0-36 months
Use of primary health care (general practitioner, emergency room, physiotherapist, and chiropractor), community care, and assistive technology during the study will be collected by linkage to the Norwegian Municipal Patient and User Register (KPR) database with the use of a unique 11-digit Norwegian national identification number for each participant.
Time frame: 12 months
Use of prescription drugs during the study will be collected by linkage to the Norwegian Prescribed Drug Registry with the use of a unique 11-digit Norwegian national identification number for each participant.
Time frame: Baseline to 36 months post-randomisation
DFS is defined as time from randomization to the first occurrence of: (i) death from any cause; (ii) incident dementia; or (iii) incident ADL disability. Participants with dementia or ADL disability at baseline are excluded from the DFS analysis.
Death: ascertained by linkage to the Norwegian Cause of Death Registry.
Incident ADL disability: score of 3-5 any of the six primary ADLs (Physical Self-Maintenance Scale) or a score of 0 for any of the five instrumental ADLs (Lawton IADL Scale). If ADL status cannot be obtained, admission to long-term nursing care (national registries) will be used as a proxy for disability.
Incident dementia: registry/clinical diagnosis (ICD-10 F00-F03, G30, or equivalent codes in national registries). Exploratory supplement: MoCA assessed at 24/36 months; dementia defined as MoCA z-score ≤ -2.0 (age/education-adjusted).
Time frame: 0-12 months
Intervention costs (resistance training and control), prescription medication, and health and care service utilisation during the 12-month intervention period. Costs for the training intervention include fitness centre membership fees and instructor labour costs (time worked + overheads). We will not consider potential travel costs for participants. We will obtain expenses related to prescription medication and health care service utilisation by linking participant data with data from the Norwegian Prescribed Drug Registry, the Norwegian Patient Registry (specialist health services), and the Municipal Patient and User Register (primary care, care services, physiotherapist, and chiropractor). We focus only on implementation costs, thus disregarding research protocol costs (e.g. recruitment).
Time frame: 0-12 months
We use the 12-item short-form health survey (SF-12) to assess health-related quality of life across eight areas, with scores summed into a physical component summary score and a mental component summary score, ranging from 0 to 100, with higher scores indicating a better quality of life.32 Next, we'll convert the SF-12 scores into SF-6D utility scores using the equation by Brazier and Roberts (2004).33 The utility scores range from 0 (equivalent to death) to 1 (equivalent to perfect health). Finally, we'll calculate QALYs for the 12-month intervention period by linearly interpolating SF-6D utility scores for baseline, six, and 12 months
Time frame: 6 and 12 months
Musculoskeletal pain assessed using the "yes" or "no" question, "during the last year have you had pain in your muscles and/or joints that lasted for at least 3 consecutive months?". When answering "yes", participants will be asked to indicate the affected body areas. In addition, we will assess pain intensity for lower back and neck, specifically, using a 10-cm visual analogue scale (VAS).
Time frame: 12 months
Echocardiographic indices of atrial and ventricular structure and function
Time frame: 0-12 and 0-36 months
During the study unreported mortality will be assessed twice per year by linkage to the Norwegian population registry with the use of a unique 11-digit Norwegian national identification number for each participant.
Time frame: 24 and 36 months
Montreal Cognitive Assessment Tool
Time frame: 12, 24, 36 months
Using the Protein Screener 55+
Time frame: 0-12 months
We will analyse the cost-effectiveness by estimating the Incremental Cost-Effectiveness Ratio (ICER) between the resistance training and control groups. We consider resistance training cost-effective if the ICER falls below the willingness-to-pay threshold (WTP).
Norwegian University of Science and Technology
Other
Reducing Falls With Progressive Resistance Training (ReFit) for the Oldest Old Adults With Sarcopenia. A 12-month Randomised Controlled Trial (RCT).
Acronym: ReFit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07275996
Aging, Atrophy
Burgos, Castille and León, Spain
View Trial DetailsNCT07494916
Aging, Atrophy
Granada, Spain
View Trial DetailsNCT07015307
Aging, Atrophy
Elche, Alicante, Spain
View Trial DetailsNCT06618430
Aging, Atrophy
Ribeirão Preto, São Paulo, Brazil
View Trial Details